At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.
Patent # | Description |
---|---|
US-9,308,299 |
Adherent metal oxide coating forming a high surface area electrode An implantable electrode and method for manufacturing the electrode wherein the electrode has a strong, adherent surface inert coating on a conductive coating... |
US-9,308,298 |
Drug releasing medical catheters, tubes, and devices The present disclosure relates to medical catheters, tubes, and other medical devices, systems, and methods. The catheter, tube, or other medical device is... |
US-9,308,297 |
Porous biocompatible polymer material and methods Embodiments described include devices and methods for forming a porous polymer material. Devices disclosed and formed using the methods described a spacer for... |
US-9,308,296 |
Tissue processing apparatus and method A tissue treatment apparatus and method for treating biologic tissue has a controller, an enclosure, a reagent supply system, a draining configuration, and a... |
US-9,308,295 |
Oxygenated demineralized bone matrix for bone growth An improved composition for inducing bone growth is provided that is a mixture of DBM and a perfluorocarbon oxygen carrier. Injection/implantation of a... |
US-9,308,294 |
Synthetic serous membranes and methods for making the same The present disclosure relates to casting-mold imprints and synthetic reproductions of serous membranes for tissue engineering and organogenesis. The imprints... |
US-9,308,293 |
Multi-modal shape memory polymers The present disclosure relates to a multi-modal shape memory polymer material comprising a blend or at least one polymer component having a first molecular... |
US-9,308,292 |
Formable and settable polymer bone composite and methods of production
thereof A composite osteoimplant. The osteoimplant includes a polymer and bone-derived particles. The composite is adapted and constructed to be formable during or... |
US-9,308,291 |
Medical pressure-sensitive adhesive sheet and method for producing the
same A medical pressure-sensitive adhesive sheet includes a urethane substrate, an interlayer adhesive layer, an olefin nonwoven fabric, and a pressure-sensitive... |
US-9,308,290 |
Water-absorbing agent, manufacture method thereof, and absorbent and
absorbent article made therefrom To improve the heat retention by diapers and other absorbents, a heat retention indicator 1 of a water-absorbing resin which is defined in the present invention... |
US-9,308,289 |
Air purifying luminaire A luminaire system having a lamp compartment and sterilization compartment permitting both illumination and the sterilizing of airborne bacteria. The... |
US-9,308,288 |
Dual scent air freshener with manual combiner An air freshener includes a pair of wicks extending from a pair of reservoirs configured to contain different scents. A hood is sized and shaped to essentially... |
US-9,308,287 |
Fragrancing system for a motor vehicle A fragrancing system for a motor vehicle, having a housing, in which a replaceable fragrance storage container is inserted, which has an opening for dispensing... |
US-9,308,286 |
Heating apparatus with a disinfection device A heating apparatus for heating and sterilizing or disinfecting a material used in dental treatment, the heating apparatus comprising a heating compartment with... |
US-9,308,285 |
Gas plasma disinfection and sterilisation apparatus A sterilization or disinfecting system in which non-thermal plasma is generated in pulses, in which pulses of microwave frequency energy are used to sustain... |
US-9,308,284 |
Formulations of fluorinated stilbene suitable for PET imaging The invention is directed to formulations of lipophilic Amyloid beta ligand stilbene and more particularly to formulations which are capable to be administered... |
US-9,308,283 |
Implants and biodegradable fiducial markers Implantable materials may be used in an iatrogenic site. Applications include radiopaque materials for fiducial marking. For instance, a method of treating... |
US-9,308,282 |
[F-18]-labelled L-glutamic acid and L-glutamine derivatives (I), their use
and processes for their preparation What is described are the compounds and the synthesis of [F-18]-labelled L-glutamic acid, [F-18]-labelled L-glutamate, their derivatives of the formula (I) and... |
US-9,308,281 |
MRNA therapy for Fabry disease Disclosed herein are compositions and methods for modulating the production of a protein in a target cell. The compositions and methods disclosed herein are... |
US-9,308,280 |
Targeting of antigen presenting cells with immunonanotherapeutics The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides nanocarriers capable... |
US-9,308,279 |
SPARC binding ScFvs The invention provides compositions comprising SPARC binding ScFc and its use. |
US-9,308,278 |
Antibody drug conjugates (ADC) that bind to 161P2F10B proteins Antibody drug conjugates (ADC's) that bind to 161P2F10B protein are described herein. 161P2F10B exhibits tissue specific expression in normal adult tissue, and... |
US-9,308,277 |
Protease-resistant mutants of stromal cell derived factor-1 in the repair
of tissue damage The present invention features mutant stromal cell derived factor-1 (SDF-1) peptides that have been mutated to make them resistant to digestion by, for example,... |
US-9,308,276 |
Combination therapy for treatment of cancer The present invention relates to methods and compositions for the treatment of cancer. Some embodiments include methods of treating cancer comprising... |
US-9,308,275 |
Method of increasing the effect of an activated-potentiated form of an
antibody The preset invention provides a method of increasing the effect of an activated-potentiated form of an antibody to an endogenous biological molecule by... |
US-9,308,274 |
Stabilized polymeric thiol reagents Disclosed are water soluble polymeric thiol reagents. Also disclosed are uses for the polymeric thiol reagents and methods for preparing the polymeric thiol... |
US-9,308,273 |
Polymer derivatives comprising an acetal or ketal branching point The invention conjugates that can be prepared by contacting a polymer comprising an acetal or ketal branching point with a pharmacologically active agent under... |
US-9,308,272 |
Compositions comprising noribogaine and an excipient to facilitate
transport across the blood brain barrier This invention relates generally to compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier. |
US-9,308,271 |
Compositions The invention relates to a dry compositions for lactic acid bacteria and in particular to a dry composition comprising from 10.sup.9 to 10.sup.13 cfu/g of the... |
US-9,308,270 |
Pharmaceutical composition on the basis of nanomicelles containing
epigallocatechin gallate and a method of... The invention relates to pharmacy. It is an object of the present invention to produce nanomicellar structures containing EGCG and achieving a positive result... |
US-9,308,269 |
Stable liquid formulations of volatile gas anesthetics A stable liquid nanoemulsion of a volatile gas anesthetic, such as, isoflurane or sevoflurane, is disclosed which is effective in inducing and maintaining a... |
US-9,308,268 |
Solubilized benzoyl peroxyde acne The invention relates to a novel solubilized benzoyl peroxide topical formulation for the treatment of acne comprising: benzoyl peroxide, one or more micelle... |
US-9,308,267 |
Lipids for therapeutic agent delivery formulations The description is directed to ionizable lipids useful for enhancing the delivery of therapeutic agents in liposomes. |
US-9,308,266 |
Liquid pharmaceutical formulations of palonosetron The present invention relates to shelf-stable liquid formulations of palonosetron for reducing chemotherapy and radiotherapy induced emesis with palonosetron.... |
US-9,308,265 |
Nanoparticles of cerium and amino acids A process for making nanoparticles of biocompatible materials is described, wherein an aqueous reaction mixture comprising cerous ion, an .alpha.-amino acid, an... |
US-9,308,264 |
Ophthalmic contact lens solutions containing forms of vitamin B The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to... |
US-9,308,263 |
Pharmaceutical compositions and uses thereof The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to... |
US-9,308,262 |
Pharmaceutical composition for administration to nails The invention provides semi-solid or liquid pharmaceutical compositions for topical administration to a finger- or toenail of a human. The compositions are... |
US-9,308,261 |
Compositions and methods for treating varicose veins The present invention provides compositions and methods for preventing or treating diseases and disorders, the composition comprising vitamin C, vitamin E, and... |
US-9,308,260 |
Anticonvulsive pharmaceutical compositions The use of substance selected from taurine, a taurine precursor, a taurine metabolite, a taurine derivative, a taurine analog and a substance required for the... |
US-9,308,259 |
Medicinal agent for treating fatness, diabetes, and diseases associated
with impaired glucose tolerance The inventive medicinal agent comprises antibodies against beta-subunit of insulin receptor in an activated form produced by means of repeated serial dilution... |
US-9,308,258 |
Stable and aggregation free antibody FC molecules through CH3 domain
interface engineering The present invention relates to methods of increasing stability and reducing aggregation in compositions comprising antibody Fc molecules and to composition... |
US-9,308,257 |
Protein formulation The present invention provides stable lyophilized formulations of bispecific antibodies or fragments thereof. |
US-9,308,256 |
Method of treating rheumatoid arthritis with an anti-IL-6R antibody The present invention provides methods of preventing or treating rheumatoid arthritis using a fully human antibody or antigen-binding fragment thereof that... |
US-9,308,255 |
Methods of administering D-dopachrome tautomerase (D-DT) to treat
ischemia-reperfusion injury The present invention relates to the discovery that reduced levels of D-dopachrome tautomerase (D-DT) (also known as MIF-2) are associated with ... |
US-9,308,254 |
Method for treatment of post operative cognitive dysfunction The present invention provides method, uses and agents for preventing or reducing cognitive decline in a patient following a planned inflammatory trigger. Such... |
US-9,308,253 |
Cancer immunotherapy We formulated multiple TLR agonists into GVAX (lethally irradiated tumor cell vaccines engineered to secrete GM-CSF). Specifically, GLA and R848, TLR4 and... |
US-9,308,252 |
Extracellular matrix materials as vaccine adjuvants for diseases
associated with infectious pathogens or toxins Disclosed are vaccines and vaccine adjuvants useful in the treatment and/or prevention of infection and diseases associated with infectious pathogens, such as... |
US-9,308,251 |
Peptide carrier fusion proteins as allergy vaccines The present invention relates to a polypeptide comprising at least three peptide fragments consisting of 10 to 50 consecutive amino acid residues of at least... |
US-9,308,250 |
Combined measles-malaria vaccine A combined measles-malaria vaccine containing different attenuated recombinant measles-malaria vectors comprising a heterologous nucleic acid encoding several... |